Skip to content

Effect of perioperative serratus anterior plane block on postoperative early pulmonary function after lung cancer surgery

Effect of perioperative serratus anterior plane block on postoperative early pulmonary function after lung cancer surgery

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024284
Enrollment
Unknown
Registered
2019-07-04
Start date
2019-07-10
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer Thoracic surgery

Interventions

Group S:Continuous serratus anterior plane block with patient-controlled analgesia
Group P:Patient-controlled intravenous analgesia

Sponsors

The First Affiliated Hospital of USTC (Anhui Provincial Hospital), Division of Life Sciences and Medicine, University of Science and Technology of China (USTC)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients undergoing unilateral thoracoscopic surgery with an ASA status II-III, male or female, aged 18-70 years, BMI 19-30 kg/m2. Preoperative normal pulmonary function, and no received radiotherapy, chemotherapy and immunosuppressive agents. The same type of surgery is operated by the same group of doctors, and written informed consent was obtained from all enrolled patients.

Exclusion criteria

Exclusion criteria: 1. History of thoracic surgery; 2. Patients with blood system diseases such as coagulation dysfunction; 3. Patients with severe abnormal cardiopulmonary, liver and kidney function; 4. Allergic to local anesthetics or opioids; 5. Infection at puncture site; 6. Patients unable to cooperate or communicate with.

Design outcomes

Primary

MeasureTime frame
FEV1 FVC;

Secondary

MeasureTime frame
Pulmonary complications;

Countries

China

Contacts

Public ContactChai Xiaoqing

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

xiaoqingchai@163.com+86 0551-62283963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026